Evidence map›Paper›PMID 36280722›Full record

ArticleNature methods2022

Geometric engineering of organoid culture for enhanced organogenesis in a dish.

Sunghee Estelle Park, Shawn Kang, Jungwook Paek, Andrei Georgescu, Jeehan Chang, Alex Yoon Yi, Benjamin J Wilkins, Tatiana A Karakasheva, Kathryn E Hamilton, Dan Dongeun Huh

Open access · greenAbstract read
In one paragraph

Article in Nature methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Suspended Tissue Open Microfluidic Patterning (STOMP).Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sunghee Estelle ParkDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
Shawn KangDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
Jungwook PaekDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
Andrei GeorgescuDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
Jeehan ChangDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
Alex Yoon YiDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
Benjamin J WilkinsDepartment of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Tatiana A KarakashevaDivision of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, USA.ORCID 0000-0001-9070-2804
Kathryn E HamiltonDivision of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Dan Dongeun HuhDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA. huhd@seas.upenn.edu.ORCID 0000-0002-5718-6884
University of Pennsylvania · USChildren's Hospital of Philadelphia · USUniversity City Science Center · US

Funding

Microphysiological systems for modeling autoimmunity in type 1 diabetesUH3DK122644 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI GADUE, PAUL J, HUH, DONGEUN · 2021 to 2023
$3.4M
Defining post-transcriptional regulons in intestinal epithelial regenerationR01DK124369 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI HAMILTON, KATHRYN ELIZABETH · 2020 to 2024
$2.6M
Probing the physics of chronic lung disease using microphysiological biomimicryDP2HL127720 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI HUH, DONGEUN · 2014 to 2014
$2.4M
Microphysiological systems for modeling autoimmunity in type 1 diabetesUG3DK122644 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI GADUE, PAUL J, HUH, DONGEUN · 2019 to 2020
$2.3M
NHLBI NIH HHS DP2 HL127720NIDDK NIH HHS R01 DK124369NIDDK NIH HHS UG3 DK122644NIDDK NIH HHS UH3 DK122644
6 · The paper itself

Abstract

Here, we introduce a facile, scalable engineering approach to enable long-term development and maturation of organoids. We have redesigned the configuration of conventional organoid culture to develop a platform that converts single injections of stem cell suspensions to radial arrays of organoids that can be maintained for extended periods without the need for passaging. Using this system, we demonstrate accelerated production of intestinal organoids with significantly enhanced structural and functional maturity, and their continuous development for over 4 weeks. Furthermore, we present a patient-derived organoid model of inflammatory bowel disease (IBD) and its interrogation using single-cell RNA sequencing to demonstrate its ability to reproduce key pathological features of IBD. Finally, we describe the extension of our approach to engineer vascularized, perfusable human enteroids, which can be used to model innate immune responses in IBD. This work provides an immediately deployable platform technology toward engineering more realistic organ-like structures in a dish.

Indexed as

Inflammatory Bowel DiseasesOrganoidsHumansIntestinesOrganogenesisStem Cells

Identifiers

PMID36280722
PMCPMC10027401
OpenAlexW4307228631

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.